Secondary Progressive multiple sclerosis (SPMS) is a common form of MS with few approved and effective therapies. Previous studies of therapeutic plasma exchange (PLEX) in SPMS have reported mixed results
objective of this study was to summarize the toxicity of mitoxantrone treatment of secondary progressive multiple sclerosis (SPMS), with particular focus on cardiotoxicity, hematological and nonhematological toxicities…
human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) in the treatment of secondary progressive multiple sclerosis. Methods: Eight patients with secondary progressive multiple scleroses were recruited from…
Introduction: Multiple Sclerosis (MS) affects approximately 110,000 people in Italy and MS is a leading cause of disability in young adults. Rehabilitation interventions are frequently used as clinical ... strategies…
Because of inadequate efficacy of immunomodulatory treatments, primary- (PPMS) and secondary-progressive multiple sclerosis (SPMS) were thought to have significantly less intrathecal inflammation than…
which medicines are mostly dedicated. Clinical course of some patients will transition to secondary progressive multiple sclerosis and small portion of patients is classified as primary progressive multiple sclerosis…
called secondary progressive multiple sclerosis. Worsening symptoms usually include mobility and gait problems. The rate of disease progression varies widely among people with secondary progressive multiple sclerosis…
monthly pulse CYC on patients with worsening relapsing-remitting multiple sclerosis (RRMS) and secondary progressive multiple sclerosis (SPMS) were evaluated. Methods: Fifty-six patients who presented with worsening RRMS
Multiple sclerosis (MS) is a chronic and debilitating disease affecting approximately 2.5 million people worldwide, and safe and effective treatment options are sorely lacking. While there are several currently approved…
sclerosis. Attempts to use pulse- therapy with methylprednisolone in the treatment of a secondary progressive multiple sclerosis are known. Intravenous methylprednisolone pulse therapy (IVMP) inhibits the inflammatory…
Ocrelizumab have emerged as crucial drugs approved for treating progressive forms of MS, particularly primary progressive and secondary progressive MS. Despite their benefits for patients experiencing clinical relapses…
year old woman with a 14 year history of secondary progressive multiple sclerosis developed new onset aphasia and disorientation. Magnetic Resonance Imaging (MRI) showed sequelae of ictal activity on diffusion
proximal motor deficit. Results: Two women-37 and 38 years old-presenting with secondary progressive multiple sclerosis, having received intra detrusor botulinum toxin injections (400 BOTOX® U and 750 DYSPORT
open prospective study with PLEX in 36 patients with progressive forms of multiple sclerosis (either secondary progressive or relapsing-progressive) and 12 patients with NMO-spectrum disease. All patients
Understand the current treatment strategies for MS. Define terms: ? Multiple Sclerosis (MS) ? Relapse ? Relapsing Remitting MS ? Secondary Progressive MS ? Primary Progressive MS ? Progressive Relapsing MS ? Clinically…
Background: Fatigue is a common debilitating symptom of multiple sclerosis (MS) but its pathophysiology remains poorly understood. Recent studies in a variety of diseases have shown dysfunction of the cardiovascular…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.